Skip to content
Home/Companies/Biotech/Rigontec

Rigontec

Biotech·Germany·Exited 2017·Held 2yr
Entry
2015
Hold
2yr
Exit
2017

Who owns Rigontec?

Rigontec was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures IV (2015 vintage) from 2015 to 2017, exited via Trade Sale. Across its history, Rigontec has been through 5 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Sunstone Life Science Ventures
Most recent investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures IV · 2015 · VC
5 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2017.
  • ·Average hold across 5 realized cycles: 3 years.
  • ·5 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Exited
Last exited in 2017 to .
Co-invest · 5 holders · 2014 · 2017
Wellington Partners
Wellington PartnersExited 2017
2014 · 2017(3yr) · Wellington Partners Life Sciences · 1998 · VC
Trade Sale · to
MOIC
–
High-Tech Gruenderfonds (HTGF)
High-Tech Gruenderfonds (HTGF)Exited 2017
2014 · 2017(3yr) · HTGF II · 2011 · VC
Trade Sale · to
MOIC
–
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundExited 2017
2014 · 2017(3yr) · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
Trade Sale · to
MOIC
–
NRW.BANK
NRW.BANKExited 2017
2014 · 2017(3yr) · NRW.Venture · 2006 · VC
Trade Sale · to
MOIC
–
Sunstone Life Science Ventures
Sunstone Life Science VenturesExited 2017
2015 · 2017(2yr) · Sunstone Life Science Ventures IV · 2015 · VC
Trade Sale · to
MOIC
–

More from Sunstone Life Science Ventures IV

Other portfolio companies in the same fund.

Oblique Therapeutics
Active
BiotechSweden· 2020
Synendos Therapeutics
Synendos Therapeutics
Active
BiotechSwitzerland· 2020
Forendo Pharma
Exited 2021
BiotechFinland· 2019
to
STipe Therapeutics
Exited 2024
BiotechDenmark· 2019
Symphogen
Exited 2020
BiotechDenmark· 2019
to
OxThera
OxThera
Active
BiotechSweden· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Rigontec

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Rigontec?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Rigontec.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue